In vivo brain electrophoresis-a novel method for chemotherapy of CNS diseases

Expert Opinion on Drug Delivery

Volumn 12, Issue 5, 2015, Pages 727-734

  Ammirati, Mario ^a   Lamki, Tariq ^a   Chitnis, Girish ^b   Yang, Xiangyu ^a   Russell, Duncan ^c   Coble, Dondrae ^c   Kaur, Balveen ^a   Knopp, Michael ^a   Moore, Sarah ^c   Ziaie, Babak ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b PURDUE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Drug delivery; Glioblastoma multiforme; in vivo electrophoresis; Novel method; Stereotactic chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM; DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEAGLE; BLOOD BRAIN BARRIER; BRAIN ELECTROPHORESIS; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CRANIOTOMY; ELECTRIC FIELD; ELECTROPHORESIS; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ANIMAL; BRAIN; BRAIN DISEASES; DOG; DRUG DELIVERY SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES; DOGS; DRUG DELIVERY SYSTEMS; ELECTROPHORESIS; FEMALE; MAGNETIC RESONANCE IMAGING; PHARMACEUTICAL PREPARATIONS;

EID: 84928334453     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2015.1014034     Document Type: Article

References (27)

1. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005;2:3-14
2. Omuro A, DeAngelis L. Glioblastoma and other malignant gliomas. A clinical review. JAMA 2013;310(17):1842-50
3. Zhou J, Atsina KB, Himes BT, et al. Novel delivery strategies for glioblastoma. Cancer J 2012;18:89-99
4. Fellner S, Bauer B, Miller DS, et al. Transport of paclitaxel (taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest 2002;110(9):1309-18
5. Hernández-Pedro NY, Rangel-López E, Magaña-Maldonado R, et al. Application of nanoparticles on diagnosis and therapy in gliomas. BioMed Res Int 2013;2013:351031
6. Sawyer AJ, Piepmeier JM, Saltzman WM. New methods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med 2006;79:141-52
7. Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res Int 2014;2014:869269
8. Bidros DS, Vogelbaum MA. Novel drug delivery strategies in neuro-oncology. Neurotherapeutics 2009;6:539-46
9. Kunwar S, Chang S, Westphal M, et al. Phase III randomized trial of CED of IL13-PE38QQR vs gliadel wafers for recurrent glioblastoma. Neuro-oncol 2010;12:871-81
10. Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev 2012;64:640-65
11. Ahn SS, Kim J, An C, et al. Preoperative imaging evaluation of head and neck cancer: comparison of 2D spin-echo and 3D THRIVE MRI techniques with resected tumours. Clin Radiol 2012;67(12):e98-104
12. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004;3:115-24
13. Rush S, Driscoll DA. Current distribution in the brain from surface electrodes. Anesth Analg 1968;47(6):717-23
14. Machado A, Rezai AR, Kopell BH, et al. Deep brain stimulation for parkinson's disease: surgical technique and perioperative management. Mov Disord 2006;21:S247-58
15. Compound Summary for CID 441203 (Cisplatin). PubChem Open Chemistry Database. National Center for Biotechnology Information, U.S. National Library of Medicine, Bethesda, MD; 2015. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/441203#section=Information-Sources [Last accessed 18 January 2015]
16. Calogero A, Porcellini A, Lombari V, et al. Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression. Cancer Cell Int 2011;11:5
17. Compound Summary for CID 441203 (Bleomycin). PubChem Open Chemistry Database. National Center for Biotechnology Information, U.S. National Library of Medicine, Bethesda, MD; 2015. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/5460769#section=Chemical-and-Physical-Properties [Last accessed 18 January 2015]
18. Mathews MS, Blickenstaff JW, Shih E, et al. Photochemical internalization of bleomycin for glioma treatment. J Biomed Opt 2012;17(5):058001
19. Boskovitz A, Wikstrand CJ, Kuan CT, et al. Monoclonal antibodies for brain tumour treatment. Expert Opin Biol Ther 2004;4:1453-71
20. Carlsson SK, Brothers SP, Wahlestedt C. Emerging treatment strategies for glioblastoma multiforme. EMBO Mol Med 2014;6(11):1359-70
21. Vlasak J, Ionescu R. Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. Curr Pharm Biotechnol 2008;9(6):468-81
22. Shahar T, Ram Z, Kanner AA. Convection-enhanced delivery catheter placements for high-grade gliomas: complications and pitfalls. J Neurooncol 2012;107:373-8
23. Meinzer M, Lindenberg R, Antonenko D, et al. Anodal transcranial direct current stimulation temporarily reverses age-associated cognitive decline and functional brain activity changes. J Neurosci 2013;33(30):12470-8
24. Poreisz C, Boros K, Antal A, et al. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull 2007;72:208-14
25. Iyer MB, Mattu U, Grafman J, et al. Safety and cognitive effect of frontal DC brain polarization in healthy individuals. Neurology 2005;64:872-5
26. Gabriel C, Peyman A, Grant EH. Electrical conductivity of tissue at frequencies below 1 MHz. Phys Med Biol 2009;54:4863-78
27. Geddes LA, Baker LE. The specific resistance of biological material-a compendium of data for the biomedical engineer and physiologist. Med Biol Eng 1967;5:271-93